Immuno 500
Immuno 500 is a specialized research peptide formulation synthesized to facilitate high-precision investigation into peptide-mediated immune signaling, cellular defense pathways, and cytokine modulation. Provided strictly for in vitro assays and laboratory animal models, this compound serves as an analytical tool for biomedical researchers exploring cell-mediated responsiveness.
Quick answer
Immuno 500 is a specialized research peptide formulation synthesized to facilitate high-precision investigation into peptide-mediated immune signaling, cellular defense pathways, and cytokine modulation. Provided strictly for in vitro assays and laboratory animal models, this compound serves as an analytical tool for biomedical researchers exploring cell-mediated responsiveness.
Key takeaways
- Immuno 500 is a specialized research peptide formulation evaluated in laboratory settings for its potential interactions with immune signaling pathways and cellular response mechanisms.
- In cell culture and animal models, Immuno 500 is studied primarily for its interaction with surface-bound signaling receptors involved in innate and adaptive immune cascades.
- Published preclinical literature regarding synthetic immunomodulatory peptides emphasizes their utility in establishing baseline cellular response metrics.
- To properly contextualize the signaling profile of Immuno 500, investigators often compare its receptor interaction kinetics against other well-characterized immunomodulatory and tissue-response compounds.
Direct Summary: What is Immuno 500?
Immuno 500 is a specialized research peptide formulation evaluated in laboratory settings for its potential interactions with immune signaling pathways and cellular response mechanisms. Supplied exclusively for in vitro and animal research models, Immuno 500 allows investigators to explore peptide-mediated immune modulation, cell surface receptor binding, and cytokine regulation without clinical or human diagnostic application.
As biomedical literature increasingly examines peptide signaling in host defense models, researchers require stable, analytical-grade compounds with fully verified sequence integrity. PX1 Research provides Immuno 500 to academic, industrial, and clinical institutions seeking traceable lot-specific data and rigorous purity standards for controlled experimental designs.
Molecular Profile and Proposed Mechanisms of Action
In cell culture and animal models, Immuno 500 is studied primarily for its interaction with surface-bound signaling receptors involved in innate and adaptive immune cascades. Preclinical evidence suggests that peptide sequences within this structural class may influence signal transducer and activator of transcription (STAT) pathways, nuclear factor kappa B (NF-κB) nuclear translocation, and downstream transcription of pro- and anti-inflammatory cytokines.
In vitro data indicate that the peptide's primary amino acid backbone maintains high target affinity in standardized receptor binding assays. Investigators frequently monitor changes in interleukin expression (e.g., IL-2, IL-6, IL-10) and interferon-gamma (IFN-γ) synthesis when exposing lymphocyte or macrophage populations to varying concentrations of Immuno 500. Understanding these pathway kinetics aids in mapping non-pathogenic immune modulation within our broader research library.
Preclinical Literature and Laboratory Observations
Published preclinical literature regarding synthetic immunomodulatory peptides emphasizes their utility in establishing baseline cellular response metrics. In rodent models, researchers have utilized compounds within this category to observe macrophage phagocytic activity, dendritic cell maturation rates, and natural killer (NK) cell cytotoxic activity under controlled stressors.
Data derived from controlled animal studies suggest that these peptides do not induce non-specific systemic overactivation; rather, they appear to modulate cellular response selectively depending on the physiological microenvironment. For laboratories evaluating multi-peptide systems or complex synergistic immune models, researchers often evaluate standalone compounds alongside structured combinations such as the Immuno Bundle to analyze downstream signaling cross-talk.
Comparative Analysis: Immuno 500 vs. Related Research Peptides
To properly contextualize the signaling profile of Immuno 500, investigators often compare its receptor interaction kinetics against other well-characterized immunomodulatory and tissue-response compounds. Each peptide class exhibits distinct primary target receptors, half-lives, and downstream physiological cascades within preclinical assays.
For instance, while Immuno 500 focuses primarily on cell-mediated pathways and cytokine modulation, Thymosin Alpha-1 is extensively studied for its specific role in T-cell maturation and toll-like receptor (TLR) activation. Concurrently, compounds like BPC-157 operate predominantly through angiogenic and tissue-repair cascades, and KPV targets α-MSH receptor pathways to dampen local inflammatory signals. A comprehensive overview of these distinct molecular tools is available in our full catalogue of research peptides.
Laboratory Handling and Reconstitution Protocols
Immuno 500 is supplied as a sterile, lyophilized cake or powder to ensure maximal solid-state stability during transit and storage. Reconstitution must be performed under a laminar flow hood using aseptic laboratory techniques to prevent microbial or chemical contamination of the sample.
For standard analytical and cell culture applications, bacteriostatic water (0.9% benzyl alcohol preserved) or sterile 0.9% sodium chloride for injection grade solution is typically added down the side of the glass vial wall. Gentle swirling or slow rotation of the vial is recommended to achieve complete dissolution. Mechanical agitation, such as vigorous shaking, should be strictly avoided to prevent peptide shear stress, foaming, or secondary structure denaturation.
Lyophilized Storage Parameters and Solution Stability
The lyophilized peptide matrix exhibits high thermal stability when stored away from moisture and direct light. Prior to reconstitution, vials of Immuno 500 should be stored at -20°C in a desiccated environment. Under these conditions, the dry peptide maintains chemical integrity and structural stability for extended research timelines.
Once reconstituted into an aqueous solution, the peptide's shelf life decreases due to potential hydrolysis or aggregation over time. Aliquoting the reconstituted liquid into single-use, low-binding microcentrifuge tubes minimizes freeze-thaw degradation cycles. Reconstituted aliquots stored at 2°C to 8°C should generally be utilized within 14 to 30 days, while aliquots frozen at -80°C remain stable for longer assay series.
Purity Verification: RP-HPLC and Mass Spectrometry Analysis
In experimental settings, minor peptide impurities or truncated sequence fragments can generate confounding assay baseline drift or false-positive receptor binding data. Therefore, high-purity material is essential for reproducible empirical outcomes. PX1 Research enforces strict batch-level analytical verification using Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) and Electrospray Ionization Mass Spectrometry (ESI-MS).
RP-HPLC analysis establishes the chromatographic purity of Immuno 500, confirming a main peak area integration exceeding 99.0%. Mass spectrometry validates the exact molecular weight and sequence identity against theoretical mass calculation. Every lot of peptide shipped from PX1 Research includes a comprehensive, lot-specific Certificate of Analysis (COA) directly downloadable by institutional purchasing departments and principal investigators.
Endotoxin Qualification and ISO 17025 Testing Standards
Bacterial endotoxins (lipopolysaccharides) represent a significant confounding variable in immune signaling research. Minute quantities of endotoxin in a peptide sample can trigger toll-like receptor 4 (TLR4) cascades, masking the intrinsic biological effects of the compound under study.
To guarantee that experimental results reflect the peptide's actual mechanism rather than contaminant artifact, PX1 Research subjects every batch to Chromogenic Recombinant Factor C (rFC) or LAL endotoxin testing performed by an independent, accredited ISO 17025 laboratory. Only lots demonstrating endotoxin levels strictly below defined threshold limits (<0.01 EU/mg) are released for distribution.
USA Manufacturing and Domestic Order Fulfillment
All synthesis, purification, lyophilization, and quality assurance processes for Immuno 500 are conducted in modern, cGMP-compliant manufacturing facilities located within the United States. Domestic manufacturing ensures strict oversight of raw material sourcing, automated solid-phase peptide synthesis (SPPS), and final container closure integrity.
Orders placed by qualified institutions are fulfilled directly from state-of-the-art dispatch facilities in California and Arizona. PX1 Research provides same-day shipping for orders confirmed Monday through Friday prior to standard cut-off times, minimizing logistics delays and temperature fluctuations during transit for research facilities operating under strict timelines. Institutional accounts and high-volume laboratory procurement protocols can be established via our wholesale portal.
Frequently Asked Questions
What is the primary intended use for Immuno 500?
Immuno 500 is synthesized strictly for in vitro laboratory assays, cell culture studies, and preclinical animal research. It is not intended for human consumption, clinical diagnostic procedures, or therapeutic use.
How is the chemical purity of Immuno 500 verified?
Purity is verified using Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) to ensure analytical purity ≥99%, and Mass Spectrometry (MS) to verify precise molecular weight and sequence identity.
What endotoxin standards apply to Immuno 500 lots?
Every lot undergoes independent ISO 17025 accredited laboratory testing to confirm endotoxin levels remain below 0.01 EU/mg, preventing contaminant-induced cellular artifacts in immune assays.
How should dry Immuno 500 be stored upon receipt?
Lyophilized vials should be stored at -20°C in a dry, dark environment. Upon receipt, desiccated freezer storage maintains maximum stability prior to reconstitution.
What diluents are suitable for reconstituting Immuno 500 for laboratory assays?
Common diluents include sterile bacteriostatic water (0.9% benzyl alcohol) or sterile 0.9% sodium chloride solution, depending on the requirements of the specific cell culture or assay protocol.
How long is reconstituted Immuno 500 stable in liquid form?
Reconstituted solutions stored at 2°C to 8°C are typically stable for 14 to 30 days. For long-term usage, single-use aliquots should be frozen at -80°C to minimize freeze-thaw cycles.
Where is Immuno 500 manufactured and shipped from?
Immuno 500 is manufactured in USA-based cGMP-compliant facilities and shipped directly from PX1 Research fulfillment centers in California and Arizona.
Can I obtain a lot-specific Certificate of Analysis (COA) for Immuno 500?
Yes. Every shipment is backed by a downloadable, lot-specific COA detailing RP-HPLC profiles, mass spectrometry data, and endotoxin assay results.
How does Immuno 500 differ structurally from Thymosin Alpha-1?
Immuno 500 and Thymosin Alpha-1 possess distinct amino acid sequences and binding affinities, leading to different target receptor profiles and downstream signaling kinetics in preclinical models.
Is same-day dispatch available for Immuno 500 orders?
Yes. PX1 Research offers same-day shipping for qualified laboratory orders placed Monday through Friday prior to the daily cutoff time from our CA and AZ facilities.
Related pages
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.